SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 108.86 |
| Enterprise Value ($M) | 34.09 |
| Book Value ($M) | 73.68 |
| Book Value / Share | 0.59 |
| Price / Book | 1.48 |
| NCAV ($M) | 71.31 |
| NCAV / Share | 0.57 |
| Price / NCAV | 1.53 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.37 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.08 |
| Current Ratio | 13.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 77.11 |
| Assets | 79.48 |
| Liabilities | 5.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.24 | 0.00 | |
| 13G | BlackRock, Inc. | 7.70 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 54,677 | 601,295 | 9.09 | |
| 181,570 | 1,157,944 | 15.68 | |
| 132,723 | 519,040 | 25.57 | |
| 110,663 | 429,157 | 25.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ASNS – Actelis Networks, Inc. | ASRT – Assertio Holdings, Inc. |
| ATNF – 180 Life Sciences Corp. | ATXI – Avenue Therapeutics, Inc. |
| ATYR – aTyr Pharma, Inc. |